WT
TARO

Washington Trust’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Washington Trust’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$13K – 1114
2021
Q3 		$13K Hold
200
– – ﹤0.01% 756
2021
Q2 		$14K Hold
200
– – ﹤0.01% 746
2021
Q1 		$15K Hold
200
– – ﹤0.01% 717
2020
Q4 		$15K Hold
200
– – ﹤0.01% 708
2020
Q3 		$11K Buy
+200
New +$12.4K ﹤0.01% 721

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Washington Trust's TARO Position: Q4 2021 in Review

Washington Trust sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2021, closing a stake of 200 shares — an estimated $13K sold.

Washington Trust first reported a position in TARO in Q3 2020 and held it in 5 quarters. The position peaked at $15K in Q1 2021. 71 funds tracked by Wall St. Rank hold TARO as of Q4 2021.

  • Washington Trust reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2021 after selling out during the quarter.
  • Washington Trust sold 200 Taro Pharmaceutical Industries Ltd. shares in Q4 2021, an estimated $13K.
  • Washington Trust first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2020 and held it in 5 quarters.
  • Washington Trust's Taro Pharmaceutical Industries Ltd. position peaked at $15K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2021.

Based on Washington Trust's 13F filing for Q4 2021, filed 9 Feb 2022.